These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 29787814

  • 1. Lipid-modified cell-penetrating peptide-based self-assembly micelles for co-delivery of narciclasine and siULK1 in hepatocellular carcinoma therapy.
    Wang X, Wu F, Li G, Zhang N, Song X, Zheng Y, Gong C, Han B, He G.
    Acta Biomater; 2018 Jul 01; 74():414-429. PubMed ID: 29787814
    [Abstract] [Full Text] [Related]

  • 2. MiR-26 enhances chemosensitivity and promotes apoptosis of hepatocellular carcinoma cells through inhibiting autophagy.
    Jin F, Wang Y, Li M, Zhu Y, Liang H, Wang C, Wang F, Zhang CY, Zen K, Li L.
    Cell Death Dis; 2017 Jan 12; 8(1):e2540. PubMed ID: 28079894
    [Abstract] [Full Text] [Related]

  • 3. Narciclasine induces autophagy-dependent apoptosis in triple-negative breast cancer cells by regulating the AMPK-ULK1 axis.
    Cao C, Huang W, Zhang N, Wu F, Xu T, Pan X, Peng C, Han B.
    Cell Prolif; 2018 Dec 12; 51(6):e12518. PubMed ID: 30152053
    [Abstract] [Full Text] [Related]

  • 4. Enhancing anti-tumor efficiency in hepatocellular carcinoma through the autophagy inhibition by miR-375/sorafenib in lipid-coated calcium carbonate nanoparticles.
    Zhao P, Li M, Wang Y, Chen Y, He C, Zhang X, Yang T, Lu Y, You J, Lee RJ, Xiang G.
    Acta Biomater; 2018 May 12; 72():248-255. PubMed ID: 29555460
    [Abstract] [Full Text] [Related]

  • 5. Substituted indole derivatives as UNC-51-like kinase 1 inhibitors: Design, synthesis and anti-hepatocellular carcinoma activity.
    Zhao LY, Li SY, Zhou ZY, Han XY, Li K, Xue ST, Jiang JD.
    Biomed Pharmacother; 2024 Sep 12; 178():117260. PubMed ID: 39116788
    [Abstract] [Full Text] [Related]

  • 6. Tumor-penetrating codelivery of siRNA and paclitaxel with ultrasound-responsive nanobubbles hetero-assembled from polymeric micelles and liposomes.
    Yin T, Wang P, Li J, Wang Y, Zheng B, Zheng R, Cheng D, Shuai X.
    Biomaterials; 2014 Jul 12; 35(22):5932-43. PubMed ID: 24746965
    [Abstract] [Full Text] [Related]

  • 7. The role of the key autophagy kinase ULK1 in hepatocellular carcinoma and its validation as a treatment target.
    Xue ST, Li K, Gao Y, Zhao LY, Gao Y, Yi H, Jiang JD, Li ZR.
    Autophagy; 2020 Oct 12; 16(10):1823-1837. PubMed ID: 31986961
    [Abstract] [Full Text] [Related]

  • 8. MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway.
    He C, Dong X, Zhai B, Jiang X, Dong D, Li B, Jiang H, Xu S, Sun X.
    Oncotarget; 2015 Oct 06; 6(30):28867-81. PubMed ID: 26311740
    [Abstract] [Full Text] [Related]

  • 9. Aptamer-functionalized peptide H3CR5C as a novel nanovehicle for codelivery of fasudil and miRNA-195 targeting hepatocellular carcinoma.
    Liu Y, Wu X, Gao Y, Zhang J, Zhang D, Gu S, Zhu G, Liu G, Li X.
    Int J Nanomedicine; 2016 Oct 06; 11():3891-905. PubMed ID: 27574422
    [Abstract] [Full Text] [Related]

  • 10. Autophagy inhibition suppresses pulmonary metastasis of HCC in mice via impairing anoikis resistance and colonization of HCC cells.
    Peng YF, Shi YH, Ding ZB, Ke AW, Gu CY, Hui B, Zhou J, Qiu SJ, Dai Z, Fan J.
    Autophagy; 2013 Dec 06; 9(12):2056-68. PubMed ID: 24157892
    [Abstract] [Full Text] [Related]

  • 11. Regulation of SIRT1/AMPK axis is critically involved in gallotannin-induced senescence and impaired autophagy leading to cell death in hepatocellular carcinoma cells.
    Kwon HY, Kim JH, Kim B, Srivastava SK, Kim SH.
    Arch Toxicol; 2018 Jan 06; 92(1):241-257. PubMed ID: 28676953
    [Abstract] [Full Text] [Related]

  • 12. Arenobufagin, a natural bufadienolide from toad venom, induces apoptosis and autophagy in human hepatocellular carcinoma cells through inhibition of PI3K/Akt/mTOR pathway.
    Zhang DM, Liu JS, Deng LJ, Chen MF, Yiu A, Cao HH, Tian HY, Fung KP, Kurihara H, Pan JX, Ye WC.
    Carcinogenesis; 2013 Jun 06; 34(6):1331-42. PubMed ID: 23393227
    [Abstract] [Full Text] [Related]

  • 13. MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity.
    Xu L, Beckebaum S, Iacob S, Wu G, Kaiser GM, Radtke A, Liu C, Kabar I, Schmidt HH, Zhang X, Lu M, Cicinnati VR.
    J Hepatol; 2014 Mar 06; 60(3):590-8. PubMed ID: 24211739
    [Abstract] [Full Text] [Related]

  • 14. Cell-penetrating Peptide-modified Targeted Drug-loaded Phase-transformation Lipid Nanoparticles Combined with Low-intensity Focused Ultrasound for Precision Theranostics against Hepatocellular Carcinoma.
    Zhao H, Wu M, Zhu L, Tian Y, Wu M, Li Y, Deng L, Jiang W, Shen W, Wang Z, Mei Z, Li P, Ran H, Zhou Z, Ren J.
    Theranostics; 2018 Mar 06; 8(7):1892-1910. PubMed ID: 29556363
    [Abstract] [Full Text] [Related]

  • 15. siRNA suppression of hTERT using activatable cell-penetrating peptides in hepatoma cells.
    Li H, He J, Yi H, Xiang G, Chen K, Fu B, Yang Y, Chen G.
    Biosci Rep; 2015 Mar 18; 35(2):. PubMed ID: 25671640
    [Abstract] [Full Text] [Related]

  • 16. Polo-like Kinase 1-targeting Chitosan Nanoparticles Suppress the Progression of Hepatocellular Carcinoma.
    Wang D, Chang R, Wang G, Hu B, Qiang Y, Chen Z.
    Anticancer Agents Med Chem; 2017 Mar 18; 17(7):948-954. PubMed ID: 27671301
    [Abstract] [Full Text] [Related]

  • 17. Isoginkgetin, a potential CDK6 inhibitor, suppresses SLC2A1/GLUT1 enhancer activity to induce AMPK-ULK1-mediated cytotoxic autophagy in hepatocellular carcinoma.
    Yao J, Tang S, Shi C, Lin Y, Ge L, Chen Q, Ou B, Liu D, Miao Y, Xie Q, Tang X, Fei J, Yang G, Tian J, Zeng X.
    Autophagy; 2023 Apr 18; 19(4):1221-1238. PubMed ID: 36048765
    [Abstract] [Full Text] [Related]

  • 18. Targeted co-delivery of Beclin 1 siRNA and FTY720 to hepatocellular carcinoma by calcium phosphate nanoparticles for enhanced anticancer efficacy.
    Wu JY, Wang ZX, Zhang G, Lu X, Qiang GH, Hu W, Ji AL, Wu JH, Jiang CP.
    Int J Nanomedicine; 2018 Apr 18; 13():1265-1280. PubMed ID: 29551896
    [Abstract] [Full Text] [Related]

  • 19. Autophagic protein ULK1 regulates FOXM1 signalling in human hepatoma cells.
    Rajak S, Raza S, Tewari A, Yadav S, Ghosh S, Yen PM, Sinha RA.
    Biochem Biophys Res Commun; 2020 Nov 19; 532(4):570-575. PubMed ID: 32900486
    [Abstract] [Full Text] [Related]

  • 20. Acid-Induced Activated Cell-Penetrating Peptide-Modified Cholesterol-Conjugated Polyoxyethylene Sorbitol Oleate Mixed Micelles for pH-Triggered Drug Release and Efficient Brain Tumor Targeting Based on a Charge Reversal Mechanism.
    Tian Y, Mi G, Chen Q, Chaurasiya B, Li Y, Shi D, Zhang Y, Webster TJ, Sun C, Shen Y.
    ACS Appl Mater Interfaces; 2018 Dec 19; 10(50):43411-43428. PubMed ID: 30508486
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.